|
[1]
|
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2023概要[J]. 中国循环杂志, 2024, 39(7): 625-660.
|
|
[2]
|
Global Obesity Observatory (2023) World Obesity Atlas 2023.
https://data.worldobesity.org/publications/?cat=19
|
|
[3]
|
Flint, A.J., Hu, F.B., Glynn, R.J., Caspard, H., Manson, J.E., Willett, W.C., et al. (2010) Excess Weight and the Risk of Incident Coronary Heart Disease among Men and Women. Obesity, 18, 377-383. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Hu, G., Barengo, N.C., Tuomilehto, J., Lakka, T.A., Nissinen, A. and Jousilahti, P. (2004) Relationship of Physical Activity and Body Mass Index to the Risk of Hypertension: A Prospective Study in Finland. Hypertension, 43, 25-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Khot, U.N. (2003) Prevalence of Conventional Risk Factors in Patients with Coronary Heart Disease. JAMA, 290, 898-904. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Després, J. (2012) Body Fat Distribution and Risk of Cardiovascular Disease: An Update. Circulation, 126, 1301-1313. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Lim, S. and Meigs, J.B. (2014) Links between Ectopic Fat and Vascular Disease in Humans. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1820-1826. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Wang, W. and Seale, P. (2016) Control of Brown and Beige Fat Development. Nature Reviews Molecular Cell Biology, 17, 691-702. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
李雁鸣, 沈成兴, 申锷. 心外膜脂肪组织与心血管疾病的研究进展[J]. 中华心血管病杂志, 2022, 50(7): 723-727.
|
|
[10]
|
Gastaldelli, A. and Basta, G. (2010) Ectopic Fat and Cardiovascular Disease: What Is the Link? Nutrition, Metabolism and Cardiovascular Diseases, 20, 481-490. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Roden, M. (2006) Mechanisms of Disease: Hepatic Steatosis in Type 2 Diabetes—Pathogenesis and Clinical Relevance. Nature Clinical Practice Endocrinology & Metabolism, 2, 335-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Manolopoulos, K.N., Karpe, F. and Frayn, K.N. (2010) Gluteofemoral Body Fat as a Determinant of Metabolic Health. International Journal of Obesity, 34, 949-959. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lee, M., Wu, Y. and Fried, S.K. (2013) Adipose Tissue Heterogeneity: Implication of Depot Differences in Adipose Tissue for Obesity Complications. Molecular Aspects of Medicine, 34, 1-11. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Abraham, T.M., Pedley, A., Massaro, J.M., Hoffmann, U. and Fox, C.S. (2015) Association between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors. Circulation, 132, 1639-1647. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Diaz, A.A., Young, T.P., Kurugol, S., Eckbo, E., Muralidhar, N., Chapman, J.K., et al. (2015) Abdominal Visceral Adipose Tissue Is Associated with Myocardial Infarction in Patients with COPD. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 2, 8-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Manolis, A.A., Manolis, T.A., Vouliotis, A. and Manolis, A.S. (2025) Metabolic Dysfunction-Associated Steatotic Liver Disease and the Cardiovascular System. Trends in Cardiovascular Medicine, 35, 258-265. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Henin, G., Loumaye, A., Leclercq, I.A. and Lanthier, N. (2024) Myosteatosis: Diagnosis, Pathophysiology and Consequences in Metabolic Dysfunction-Associated Steatotic Liver Disease. JHEP Reports, 6, Article 100963. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Patel, V.B., Shah, S., Verma, S. and Oudit, G.Y. (2017) Epicardial Adipose Tissue as a Metabolic Transducer: Role in Heart Failure and Coronary Artery Disease. Heart Failure Reviews, 22, 889-902. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ibrahim, M.M. (2009) Subcutaneous and Visceral Adipose Tissue: Structural and Functional Differences. Obesity Reviews, 11, 11-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Mosalmanzadeh, N. and Pence, B.D. (2024) Oxidized Low-Density Lipoprotein and Its Role in Immunometabolism. International Journal of Molecular Sciences, 25, Article 11386. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Scott, D.A., Ponir, C., Shapiro, M.D. and Chevli, P.A. (2024) Associations between Insulin Resistance Indices and Subclinical Atherosclerosis: A Contemporary Review. American Journal of Preventive Cardiology, 18, Article 100676. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Hotamisligil, G.S., Shargill, N.S. and Spiegelman, B.M. (1993) Adipose Expression of Tumor Necrosis Factor-Α: Direct Role in Obesity-Linked Insulin Resistance. Science, 259, 87-91. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Lim, S. and Meigs, J.B. (2013) Ectopic Fat and Cardiometabolic and Vascular Risk. International Journal of Cardiology, 169, 166-176. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Smith, S.R. and Wilson, P.W.F. (2006) Free Fatty Acids and Atherosclerosis—Guilty or Innocent? The Journal of Clinical Endocrinology & Metabolism, 91, 2506-2508. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Van Gaal, L.F., Mertens, I.L. and De Block, C.E. (2006) Mechanisms Linking Obesity with Cardiovascular Disease. Nature, 444, 875-880. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Stamler, J., Stamler, R., Neaton, J.D., Wentworth, D., Daviglus, M.L., Garside, D., et al. (1999) Low Risk-Factor Profile and Long-Term Cardiovascular and Noncardiovascular Mortality and Life Expectancy: Findings for 5 Large Cohorts of Young Adult and Middle-Aged Men and Women. JAMA, 282, 2012-2018. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Brunt, E.M. (2001) Nonalcoholic Steatohepatitis: Definition and Pathology. Seminars in Liver Disease, 21, 3-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Younossi, Z.M., Koenig, A.B., Abdelatif, D., Fazel, Y., Henry, L. and Wymer, M. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Disease—Meta‐Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology, 64, 73-84. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Diehl, A.M. and Day, C. (2017) Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. New England Journal of Medicine, 377, 2063-2072. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Stefan, N., Häring, H. and Cusi, K. (2019) Non-Alcoholic Fatty Liver Disease: Causes, Diagnosis, Cardiometabolic Consequences, and Treatment Strategies. The Lancet Diabetes & Endocrinology, 7, 313-324. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Allen, A.M., Therneau, T.M., Larson, J.J., Coward, A., Somers, V.K. and Kamath, P.S. (2018) Nonalcoholic Fatty Liver Disease Incidence and Impact on Metabolic Burden and Death: A 20 Year‐Community Study. Hepatology, 67, 1726-1736. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., et al. (2015) Fibrosis Stage Is the Strongest Predictor for Disease‐Specific Mortality in NAFLD after up to 33 Years of Follow‐Up. Hepatology, 61, 1547-1554. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Castillo-Núñez, Y., Almeda-Valdes, P., González-Gálvez, G. and Arechavaleta-Granell, M.R. (2024) Metabolic Dysfunction-Associated Steatotic Liver Disease and Atherosclerosis. Current Diabetes Reports, 24, 158-166. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Ma, G., Xu, G. and Huang, H. (2025) Correlation between Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Coronary Atherosclerosis in Eastern China. Diabetology & Metabolic Syndrome, 17, Article No. 16. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Platek, A.E. and Szymanska, A. (2023) Metabolic Dysfunction-Associated Steatotic Liver Disease as a Cardiovascular Risk Factor. Clinical and Experimental Hepatology, 9, 187-192. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Iacobellis, G. (2015) Local and Systemic Effects of the Multifaceted Epicardial Adipose Tissue Depot. Nature Reviews Endocrinology, 11, 363-371. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Bodenstab, M.L., Varghese, R.T. and Iacobellis, G. (2024) Cardio-Lipotoxicity of Epicardial Adipose Tissue. Biomolecules, 14, Article 1465. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Corradi, D., Maestri, R., Callegari, S., Pastori, P., Goldoni, M., Luong, T.V., et al. (2004) The Ventricular Epicardial Fat Is Related to the Myocardial Mass in Normal, Ischemic and Hypertrophic Hearts. Cardiovascular Pathology, 13, 313-316. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Ansaldo, A.M., Montecucco, F., Sahebkar, A., Dallegri, F. and Carbone, F. (2019) Epicardial Adipose Tissue and Cardiovascular Diseases. International Journal of Cardiology, 278, 254-260. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Chen, H., Liu, L., Li, M., Zhu, D. and Tian, G. (2023) Epicardial Adipose Tissue-Derived Leptin Promotes Myocardial Injury in Metabolic Syndrome Rats through PKC/NADPH Oxidase/ROS Pathway. Journal of the American Heart Association, 12, e029415. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Mahabadi, A.A., Massaro, J.M., Rosito, G.A., Levy, D., Murabito, J.M., Wolf, P.A., et al. (2008) Association of Pericardial Fat, Intrathoracic Fat, and Visceral Abdominal Fat with Cardiovascular Disease Burden: The Framingham Heart Study. European Heart Journal, 30, 850-856. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Tachibana, M., Miyoshi, T., Osawa, K., Toh, N., Oe, H., Nakamura, K., et al. (2016) Measurement of Epicardial Fat Thickness by Transthoracic Echocardiography for Predicting High-Risk Coronary Artery Plaques. Heart and Vessels, 31, 1758-1766. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Aprigliano, G., Scuteri, L., Iafelice, I., Li Volsi, L., Cuko, B., Palloshi, A., et al. (2015) Epicardial Adipose Tissue Thickness and Acute Coronary Syndrome: A Matter of How Much or How? International Journal of Cardiology, 199, 8-9. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Nogajski, Ł., Mazuruk, M., Kacperska, M., Kurpias, M., Mączewski, M., Nowakowski, M., et al. (2024) Epicardial Fat Density Obtained with Computed Tomography Imaging—More Important than Volume? Cardiovascular Diabetology, 23, Article No. 389. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Oikonomou, E.K., Marwan, M., Desai, M.Y., Mancio, J., Alashi, A., Hutt Centeno, E., et al. (2018) Non-Invasive Detection of Coronary Inflammation Using Computed Tomography and Prediction of Residual Cardiovascular Risk (The CRISP CT Study): A Post-Hoc Analysis of Prospective Outcome Data. The Lancet, 392, 929-939. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Alberti, K.G.M.M., Zimmet, P. and Shaw, J. (2006) Metabolic Syndrome—A New World‐Wide Definition. a Consensus Statement from the International Diabetes Federation. Diabetic Medicine, 23, 469-480. [Google Scholar] [CrossRef] [PubMed]
|